Has Sally Sharp received payments from drug or device companies?

Yes. Drug and device makers reported $3,659 in general payments to Sally Sharp across 191 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sally Sharp did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sally Sharp come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sally Sharp

Psychiatric/Mental Health · Ridgeland, MSNPI 1992424279

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 191 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 15.2% — the pattern of someone who eats at a lot of different presentations.

$3,659in general payments, 2019–2025

Across 191 payments — averaging $19.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$556
Axsome Therapeutics, Inc.$517
Corium, LLC$408
Ironshore Pharmaceuticals Inc.$349
Lundbeck LLC$310
Supernus Pharmaceuticals, Inc.$296
plus $1K from 9 others

What the payments were for

Food & beverage$3,659100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	34	$556
Axsome Therapeutics, Inc.	25	$517
Corium, LLC	23	$408
Ironshore Pharmaceuticals Inc.	21	$349
Lundbeck LLC	15	$310
Supernus Pharmaceuticals, Inc.	10	$296
Otsuka America Pharmaceutical, Inc.	15	$292
Takeda Pharmaceuticals U.S.A., Inc.	13	$227
Collegium Pharmaceutical, Inc.	12	$200
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	7	$155
Vanda Pharmaceuticals Inc.	6	$152
Idorsia Pharmaceuticals US Inc	5	$80
Neurocrine Biosciences, Inc.	3	$76
Alkermes, Inc.	1	$23
Otsuka Pharmaceutical Development & Commercialization, Inc.	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

QELBREE$169

How this compares

$3,659 in reported general payments places this provider in the 85th percentile of 486 psychiatric/mental health providers in Mississippi.

See all psychiatric/mental health providers in Mississippi →

Other psychiatric/mental health in Ridgeland

Daniel HollowayRidgeland$9K
Carrie GholstonRidgeland$6K
Chyanne NappRidgeland$5K
Ashley KarelVicksburg$129K
Amanda HamCorinth$64K
Alanna WrightJackson$58K
Amanda ThomasTupelo$41K
Amelia KelleyMeridian$38K
Belinda EdwardsJackson$29K
Lawanda GlassCleveland$22K

See the full list for Mississippi →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →